MENU
+Compare
ADCT
Stock ticker: NYSE
AS OF
Apr 24, 01:39 PM (EDT)
Price
$1.34
Change
+$0.05 (+3.88%)
Capitalization
121.99M

ADCT ADC Therapeutics SA Forecast, Technical & Fundamental Analysis

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ADCT with price predictions
Apr 23, 2025

ADCT in upward trend: price expected to rise as it breaks its lower Bollinger Band on March 21, 2025

ADCT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where ADCT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ADCT's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 21, 2025. You may want to consider a long position or call options on ADCT as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ADCT just turned positive on April 17, 2025. Looking at past instances where ADCT's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADCT advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

ADCT moved below its 50-day moving average on March 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ADCT crossed bearishly below the 50-day moving average on March 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADCT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ADCT entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.056). P/E Ratio (0.000) is within average values for comparable stocks, (63.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.687) is also within normal values, averaging (252.992).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ADCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADCT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ADCT is expected to report earnings to rise 60.68% to -40 cents per share on May 12

ADC Therapeutics SA ADCT Stock Earnings Reports
Q1'25
Est.
$-0.40
Q4'24
Beat
by $0.18
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.17
The last earnings report on March 27 showed earnings per share of -25 cents, beating the estimate of -43 cents. With 18.69K shares outstanding, the current market capitalization sits at 121.99M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICPUX5.460.04
+0.74%
Integrity Mid-North American Resources C
MINVX27.30N/A
N/A
Madison Large Cap Y
HFMCX21.68N/A
N/A
Hartford MidCap A
EKJFX11.20N/A
N/A
Allspring Premier Large Co Gr R6
JTQIX14.37N/A
N/A
JHancock ESG International Equity I

ADCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+4.88%
QTTB - ADCT
51%
Loosely correlated
-1.05%
CLRB - ADCT
47%
Loosely correlated
+2.48%
PRME - ADCT
42%
Loosely correlated
+4.14%
ANAB - ADCT
41%
Loosely correlated
-5.47%
AURA - ADCT
41%
Loosely correlated
+0.88%
More